Familiáris hiperkoleszterinémia: vizsgálatok itt: Új-Zéland
7 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleA Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- Where
- Christchurch
- Életkor
- 6 év to 17 év
- People
- 153 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07058077 · EU 2024-519068-42-00 - 1. fázisTaking peopleA Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
- Where
- Christchurch, Papatoetoe
- Életkor
- 18 év to 70 év
- People
- 64 worldwide
- Run by
- Monash University
See details and how to joinNCT07428473 - 1. fázisTaking peopleA Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- Where
- Auckland, Christchurch
- Életkor
- 18 év to 75 év
- People
- 90 worldwide
- Run by
- CRISPR Therapeutics AG
See details and how to joinNCT07491172 - 1. fázisTaking peopleA Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
- Where
- Christchurch
- Életkor
- 18 év to 70 év
- People
- 85 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06164730 - 3. fázisNot yet taking people in Új-ZélandLong-Term Efficacy and Safety of Lerodalcibep in Children and Adolescents With Familial Hypercholesterolemia
- Where
- Christchurch
- Életkor
- 6 év to 17 év
- People
- 150 worldwide
- Run by
- LIB Therapeutics LLC
See details and how to joinNCT07775339 · EU 2026-528022-38-00 - 3. fázisCsak meghívásosStudy to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH
- Where
- Christchurch
- Életkor
- 6 év to 17 év
- People
- 150 worldwide
- Run by
- LIB Therapeutics LLC
See details and how to joinNCT07102511 · EU 2025-524214-28-00 - No phaseCsak meghívásosLong-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular Disease
- Where
- Auckland, Christchurch
- Életkor
- 18 év and over
- People
- 116 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06112327